Breakthrough bacteraemia with a susceptible Enterococcus faecalis during tigecycline monotherapy

J Antimicrob Chemother. 2010 Feb;65(2):370-4. doi: 10.1093/jac/dkp455. Epub 2009 Dec 18.

Authors

Mirella Parsonage¹, Shital Shah, Peter Moss, Hiten Thaker, Rolf Meigh, Ariyur Balaji, James Elston, Gavin Barlow

Affiliation

¹ Department of Infection & Tropical Medicine, Castle Hill Hospital, Hull and East Yorkshire Hospitals NHS Trust, Cottingham, East Yorkshire HU16 5JT, UK. mparsonage@btopenworld.com

PMID: 20022936
DOI: 10.1093/jac/dkp455

No abstract available

Publication types

Case Reports

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use*
Bacteremia / drug therapy*
Bacteremia / microbiology*
Enterococcus faecalis / drug effects*
Enterococcus faecalis / isolation & purification
Gram-Positive Bacterial Infections / drug therapy*
Gram-Positive Bacterial Infections / microbiology*
Humans
Microbial Sensitivity Tests
Middle Aged
Minocycline / analogs & derivatives*
Minocycline / pharmacology
Minocycline / therapeutic use
Tigecycline

Substances

Anti-Bacterial Agents
Tigecycline
Minocycline